Display options
Share it on

World J Clin Cases. 2015 Jun 16;3(6):525-32. doi: 10.12998/wjcc.v3.i6.525.

Variant of multiple sclerosis with dementia and tumefactive demyelinating brain lesions.

World journal of clinical cases

Sherifa A Hamed

Affiliations

  1. Sherifa A Hamed, Department of Neurology and Psychiatry, Hospital of Neurology and Psychiatry, Assiut University Hospital, Assiut 71516, Egypt.

PMID: 26090374 PMCID: PMC4468900 DOI: 10.12998/wjcc.v3.i6.525

Abstract

We describe an unusual clinical and diagnostic feature of a patient with multiple sclerosis (MS). A 25-year-old woman was admitted to the Neurology department (December 2009) with one month history of rapid cognitive deterioration. She had poor cognition, dysphasia, reduction in visual acuity and temporal pallor of the optic discs. She had prolonged latencies of P100 component of visual evoked potentials (VEPs). Magnetic resonance imaging (MRI)-brain showed multifocal large (≥ 3 cm) white-matter hypointense lesions in T1W and hyperintense in T2W and fluid-attenuated inversion recovery images and patchy enhancement. A diagnosis of tumefactive MS was given. She received two consecutive 5-d courses of 1 g daily intravenous methylprednisolone for 2 mo and oral prednisolone in dose of 80 mg twice/daily in between. At the 3(rd) month, Mini Mental State Examination and VEPs returned to normal but not the MRI. Patient continued oral steroids after hospital discharge (March 2010) for 9 mo with significant MRI improvement after which tapering of steroids started for a year. The patient refused immunomodulation therapy due to her low socioeconomic status. Neither clinical relapse nor new MRI lesions were observed throughout the next 4 years. In spite of the aggressive course of tumefactive MS variant, good prognosis may be seen in some patients.

Keywords: Acute dementia; Tumefactive multiple sclerosis

References

  1. J Neurol Neurosurg Psychiatry. 2013 Sep;84(9):1047-53 - PubMed
  2. JAMA Neurol. 2014 Jul 1;71(7):918-9 - PubMed
  3. Arch Neurol. 2006 Jul;63(7):964-8 - PubMed
  4. J Neurol Sci. 2010 Oct 15;297(1-2):29-35 - PubMed
  5. J Neuroimaging. 2011 Apr;21(2):e69-77 - PubMed
  6. Clin Rheumatol. 2012 Jan;31(1):123-32 - PubMed
  7. Ann Neurol. 2001 Jul;50(1):121-7 - PubMed
  8. Neurol Sci. 2011 Dec;32(6):1195-201 - PubMed
  9. Neurology. 1996 Apr;46(4):907-11 - PubMed
  10. J Neurol. 2013 Aug;260(8):2016-22 - PubMed
  11. Neurology. 2001 May 22;56(10 ):1313-8 - PubMed
  12. Brain. 2008 Jul;131(Pt 7):1759-75 - PubMed
  13. J Neurol Sci. 2013 Jan 15;324(1-2):156-62 - PubMed
  14. Neuroimaging Clin N Am. 2008 Nov;18(4):589-622, ix-x - PubMed
  15. Mult Scler. 2005 Dec;11(6):731-4 - PubMed
  16. Mult Scler. 2012 Jul;18(7):1045-9 - PubMed
  17. Tuber Lung Dis. 1995 Jun;76(3):271-2 - PubMed
  18. Neurosurg Rev. 2009 Apr;32(2):171-9; discussion 179 - PubMed
  19. Neurol Clin. 2005 Feb;23(1):61-75, vi - PubMed
  20. AJR Am J Roentgenol. 1989 May;152(5):1073-85 - PubMed
  21. Oncology. 2010;79(3-4):306-12 - PubMed
  22. AJNR Am J Neuroradiol. 2001 Aug;22(7):1362-7 - PubMed
  23. J Clin Neurosci. 2012 Jun;19(6):910-2 - PubMed
  24. Autoimmun Rev. 2010 Mar;9(5):A387-94 - PubMed
  25. Arch Neurol. 2007 Oct;64(10):1426-32 - PubMed
  26. Br J Radiol. 2003 Sep;76(909):662-5 - PubMed
  27. J Neuroradiol. 1999 Jun;26(2):101-17 - PubMed
  28. Lancet Neurol. 2011 Dec;10(12):1065-73 - PubMed
  29. Rev Neurol (Paris). 2011 Jan;167(1):14-22 - PubMed
  30. South Med J. 2002 Oct;95(10):1180-6 - PubMed
  31. AJR Am J Roentgenol. 2004 Jan;182(1):195-9 - PubMed
  32. J Rheumatol. 2005 Aug;32(8):1459-6 - PubMed
  33. J Neurol. 2008 Jan;255(1):1-10 - PubMed
  34. Neurology. 2002 Jan 22;58(2):169-78 - PubMed
  35. Ann Neurol. 2003 Jun;53(6):718-24 - PubMed

Publication Types